Induction of inhibitory receptors on T cells during plasmodium vivax malaria impairs cytokine production

Journal of Infectious Diseases

Volumn 212, Issue 12, 2015, Pages 1999-2010

  Costa, Pedro A C ^a   Leoratti, Fabiana M S ^a   Figueiredo, Maria M ^a   Tada, Mauro S ^b   Pereira, Dhelio B ^b   Junqueira, Caroline ^a   Soares, Irene S ^c   Barber, Daniel L ^d   Gazzinelli, Ricardo T ^a,e   Antonelli, Lis R V ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro de Pesquisa em Medicina Tropical CEPEM   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Malaria; Plasmodium vivax; Regulatory molecules; T cells

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ACTIVATION GENE 3; MEMBRANE PROTEIN; MUCIN 3; PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE FUNCTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETICULOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; ANTAGONISTS AND INHIBITORS; FEMALE; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PARASITOLOGY; PLASMODIUM VIVAX; YOUNG ADULT;

ADULT; CYTOKINES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84959440940     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv306     Document Type: Article

References (50)

1. Guerra CA, Howes RE, Patil AP, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLOS Negl Trop Dis 2010; 4:e774.
2. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004; 4:169-80.
3. Crompton PD, Moebius J, Portugal S, et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol 2014; 32:157-87.
4. Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. Innate sensing of malaria parasites. Nat Rev Immunol 2014; 14:744-57.
5. Franks S, Koram KA, Wagner GE, et al. Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis 2001; 183:796-804.
6. Katsuragawa TH, Gil LH, Tada MS, et al. The dynamics of transmission and spatial distribution of malaria in riverside areas of Porto Velho, Rondonia, in the Amazon region of Brazil. PLOS One 2010; 5:e9245.
7. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9:725-32.
8. Clark IA, Alleva LM, Mills AC, Cowden WB. Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004; 17:509-39, table.
9. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002; 415:673-9.
10. Elliott SR, Spurck TP, Dodin JM, et al. Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect Immun 2007; 75:3621-32.
11. Seixas E, Cross C, Quin S, Langhorne J. Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi. Eur J Immunol 2001; 31:2970-8.
12. Sponaas AM, Cadman ET, Voisine C, et al. Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J Exp Med 2006; 203:1427-33.
13. Elhassan IM, Hviid L, Satti G, et al. Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmo-dium falciparum malaria. Am J Trop Med Hyg 1994; 51:372-9.
14. Kern P, Dietrich M, Hemmer C, Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun 2000; 68:3061-3.
15. Xu H, Wipasa J, Yan H, et al. The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med 2002; 195:881-92.
16. Ha SJ, West EE, Araki K, Smith KA, Ahmed R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol Rev 2008; 223:317-33.
17. Esch KJ, Juelsgaard R, Martinez PA, Jones DE, Petersen CA. Programmed death 1-mediated T cell exhaustion during visceral leishman-iasis impairs phagocyte function. J Immunol 2013; 191:5542-50.
18. Gutierrez FR, Mariano FS, Oliveira CJ, et al. Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. Infect Immun 2011; 79:1873-81.
19. Bhadra R, Gigley JP, Weiss LM, Khan IA. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci USA 2011; 108:9196-201.
20. Rtavanis-Tsakonas K, Tongren JE, Riley EM. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 2003; 133:145-52.
21. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237:1210-2.
22. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992; 89:3200-3.
23. Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to plasmodi-um-induced acute immune pathology. PLOS Pathog 2012; 8:e1002504.
24. Kinter AL, Godbout EJ, McNally JP, et al. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008; 181:6738-46.
25. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-7.
26. Butler NS, Moebius J, Pewe LL, et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 2012; 13:188-95.
27. Horne-Debets JM, Faleiro R, Karunarathne DS, et al. PD-1 dependent exhaustion of CD8 T cells drives chronic malaria. Cell Rep 2013; 5:1204-13.
28. Lepenies B, Gaworski I, Tartz S, Langhorne J, Fleischer B, Jacobs T. CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections. Microbes Infect 2007; 9:687-94.
29. Illingworth J, Butler NS, Roetynck S, et al. Chronic exposure to Plasmo-dium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 2012; 190:1038-47.
30. Kimura M, Kaneko O, Liu Q, et al. Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. Parasitol Int 1997; 46:91-5.
31. Carvalho BO, Lopes SC, Nogueira PA, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis 2010; 202:638-47.
32. Ihalamulla RL, Mendis KN. Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Per-coll) gradient centrifugation. Trans R Soc Trop Med Hyg 1987; 81:25-8.
33. Noulin F, Borlon C, van den EP, et al. Cryopreserved reticulocytes derived from hematopoietic stem cells can be invaded by cryopreserved Plasmodium vivax isolates. PLOS One 2012; 7:e40798.
34. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4.
35. Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009; 10:29-37.
36. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-5.
37. Noulin F, Borlon C, Van Den AJ, D'Alessandro U, Erhart A. 1912-2012: a century of research on Plasmodium vivax in vitro culture. Trends Par-asitol 2013; 29:286-94.
38. Gautam S, Kumar R, Singh N, et al. CD8 T cell exhaustion in human visceral leishmaniasis. J Infect Dis 2013; 209:290-9.
39. Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLOS Pathog 2009; 5:e1000313.
40. Jones RB, Ndhlovu LC, Barbour JD, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205:2763-79.
41. Bruniquel D, Borie N, Hannier S, Triebel F. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II. Immunogenetics 1998; 48:116-24.
42. Cho HY, Lee SW, Seo SK, Choi IW, Choi I, Lee SW. Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages. Biochim Biophys Acta 2008; 1779:811-9.
43. Gong JH, Zhang M, Modlin RL, et al. Interleukin-10 downregulates My-cobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996; 64:913-8.
44. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007; 81:1258-68.
45. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010; 16:452-9.
46. Andrade BB, Reis-Filho A, Souza-Neto SM, et al. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 2010; 9:13.
47. McMahan RH, Golden-Mason L, Nishimura MI, et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010; 120:4546-57.
48. Yamamoto T, Price DA, Casazza JP, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood 2011; 117:4805-15.
49. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010; 207:2187-94.
50. Fourcade J, Sun Z, Benallaoua M, et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 2010; 207:2175-86.